Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Family Medicine
Dermatitis, Atopic Clinical Trials
A listing of Dermatitis, Atopic medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Mobile :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Arizona
Hot Springs :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
California
Cypress : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Encino :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Glendale : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Oceanside :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
San Diego :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Colorado
Denver :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Denver : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Florida
Jacksonville :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Miami :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Miami : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Miramar :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Orange Park :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
View More »
Pinellas Park :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Tampa :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Tampa :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Idaho
Boise :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Illinois
Arlington Heights :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Chicago : Northwestern University, Department of Dermatology
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
Indiana
Carmel :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Michigan
Fort Gratiot :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Minnesota
Fridley :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
New Jersey
Berlin :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Verona :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
New York
New York : Call for Information (Investigational Site 0002) Updated
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
Stony Brook :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
North Carolina
High Point :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Salem :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Winston-Salem : Wake Forest University Health Sciences
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Ohio
South Euclid :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Sylvania :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Oregon
Lake Oswego :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Portland :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Portland :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Portland : Oregon Health & Science University Center for Health & Healing
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
Portland : Oregon Health & Science University, Department of Dermatology
Eczema Prevention Study
View More »
Portland :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Portland : Oregon Health & Science University Department of Dermatology
VANOS Cream and Skin Barrier Function
Pennsylvania
Philadelphia : Registry
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
Pittsburgh : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Rhode Island
Johnston :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Texas
Austin :
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
College Station :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
College Station :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Dallas :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Houston : University of Texas Medical School - Houston
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
View More »
San Antonio :
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
San Antonio :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Webster :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Utah
Draper :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Virginia
Henrico :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Norfolk :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Washington
Spokane :
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Wisconsin
Madison : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Austria
Vienna : Novartis Investigative Site
A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
Canada
Kirkland : Merck Frosst Canada Ltd. Updated
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)
China
Beijing :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Chongqing :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Guangzhou :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Shanghai :
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Czech Republic
Nachod :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Svitavy :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Usti nad Labem :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Estonia
Tallinn :
Emollients in the Management of Atopic Dermatitis
Tartu :
Emollients in the Management of Atopic Dermatitis
Finland
Helsinki :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Tampere :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Germany
Berlin : Universitätsmedizin Charité Berlin, Abteilung für Dermatologie und Allergologie
Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
Berlin :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Berlin :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Bonn :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Dresden :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
View More »
Erfurt :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Frankfurt :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Frankfurt :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Gera :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Hannover :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Heidelberg :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Kiel :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Mahlow :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Mainz :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Münster : Universitätsklinikum Münster, Klinik für Hautkrankheiten
Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis
Münster :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Osnabrueck :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Tuebingen :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Hungary
Kaposvar :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szeged :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szekszard :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Szolnok :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lithuania
Vilnius :
Emollients in the Management of Atopic Dermatitis
Poland
Bydgoszcz :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Gdansk :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lodz :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Lublin :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Poznan :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
View More »
Warszawa :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Warszawa :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Witosa :
Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
Wroclaw :
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Sweden
Stockholm : Sophiahemmet
Effect of Moisturizing Creams on Skin Barrier Function
Taiwan
United Kingdom
Manchester : Local Institution
A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis